A team of researchers led by Dr. Cecilia Laterza and Dr. Gianvito Martino at the San Raffaele Hospital have found a novel use of neural stem cells to modulate damage caused by multiple sclerosis. Stem cells injected into mice with MS travelled to sites of inflammation and secreted factors to promote growth of myelin-producing cells and limit the inflammation caused by the strong immune attack.
Multiple Sclerosis affects more than 2.3 million people worldwide, causing 18,000 deaths per year. According to Dr. Laterza, further clinical research of this novel use of stem cells “…could pave the way for personalized stem cell treatments” to mitigate the nerve damage caused by MS.
We believe the best stem cells to use in these emerging regenerative treatments will be the patient’s own [autologous stem cells] as this negates the need to find a suitable donor and eliminates the chances of rejection of the transplanted tissue. To learn more about banking your own valuable stem cells to insure your family’s future health, visit www.StemSave.com or call 877-783-6728 (877-StemSave) today.
To view the full article, click here.
The Future of Regenerative Medicine is Now™.